Silver Nanoparticles and Neurotoxicity: Mechanistic Insights and Recent Experimental Evidence
Pharmaceutics · 29.04.2026 · 18 (5) · 545
DOI: 10.3390/pharmaceutics18050545 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 29.04.2026. Verfasst von Melis Kaya und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biology and Genetics, Çanakkale Onsekiz Mart University, Çanakkale 17100, Türkiye. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 112 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Silver nanoparticles (AgNPs) have gained significant interest across various areas arising from their multifunctional mechanisms. Biomedical applications are one of the areas where the therapeutic and diagnostic potential of AgNPs are highlighted. Considering the expansion of biomedical use of AgNPs, nervous system-based applications, including neuroimaging, neural implant coatings and development of neural tissue-targeted drug delivery systems are some of the potential applications of AgNPs in the current research. However, growing interest in these nervous system related applications and the limited regenerative capacity of neural tissues make it essential to carefully evaluate the potential neurotoxic effects of AgNPs. AgNP-induced responses in neural tissues may differ according to key physicochemical and exposure-related parameters, specifically particle size, shape, surface chemistry, coating properties, protein corona formation, exposure route, dose, and duration. Among the possible mechanisms that may contribute to these responses are blood–brain barrier (BBB) disruption, mitochondrial dysfunction and oxidative stress, neuroinflammation and glial activation, and cell death processes such as apoptosis, autophagy, and ferroptosis. In this review, in the context of the potential neurotoxic effects of AgNPs on the nervous system, the main parameters that determine AgNP neurotoxicity and the possible mechanisms involved are examined in detail, where recent scientific developments in this field are evaluated based on current in vitro and in vivo studies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Molecular Biology and Genetics, Çanakkale Onsekiz Mart University, Çanakkale 17100, Türkiye.
- European Institute for Membranes (IEM), UMR-5635, University Montpellier, ENSCM, CNRS, Place Eugène Bataillon, CEDEX 5, F-34095 Montpellier, France.
ORCID-Profile: Melis Kaya, Emir Akdaşçi, Furkan Eker, Mikhael Bechelany
Zitieren
APA
Kaya, M., Akdaşçi, E., Eker, F., Bechelany, M., & Karav, S. (2026). Silver Nanoparticles and Neurotoxicity: Mechanistic Insights and Recent Experimental Evidence. Pharmaceutics, 18(5), 545. https://doi.org/10.3390/pharmaceutics18050545
Vancouver
Kaya M, Akdaşçi E, Eker F, Bechelany M, Karav S. Silver Nanoparticles and Neurotoxicity: Mechanistic Insights and Recent Experimental Evidence. Pharmaceutics. 2026;18(5):545. doi:10.3390/pharmaceutics18050545
BibTeX
@article{Kaya2026,
author = {Kaya, Melis and Akdaşçi, Emir and Eker, Furkan and Bechelany, Mikhael and Karav, Sercan},
title = {Silver Nanoparticles and Neurotoxicity: Mechanistic Insights and Recent Experimental Evidence},
journal = {Pharmaceutics},
year = {2026},
volume = {18},
number = {5},
pages = {545},
doi = {10.3390/pharmaceutics18050545}
}
EUVIMED